Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
Harvard School of Public Health, Boston, MA, USA. marlink@hsph.harvard.edu
Marlink
Richard
R
Forsythe
Steven
S
Bertozzi
Stefano M
SM
Muirhead
Debbie
D
Holmes
Marionette
M
Sturchio
Jeffrey
J
D044966:Anti-Retroviral Agents / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics; D006285:Health Planning / Q000379:methods*; D006801:Humans; D019057:Quality-Adjusted Life Years
D044966:Anti-Retroviral Agents